40482-12-0

Usage

Uses

Used in Pharmaceutical Industry:
CIS-(2-AMINO-CYCLOPENTYL)-METHANOL is used as a key intermediate in the synthesis of antiviral drugs, anti-cancer agents, and antibiotics. Its unique structure allows for the development of novel therapeutic agents with improved efficacy and selectivity.
Used in Organic Chemistry:
In the field of organic chemistry, CIS-(2-AMINO-CYCLOPENTYL)-METHANOL serves as a valuable component in the development of new synthetic methodologies. Its presence in reactions can facilitate the formation of complex molecules, expanding the scope of organic synthesis.
Used in Research and Development:
CIS-(2-AMINO-CYCLOPENTYL)-METHANOL has potential applications in the research and development of new materials and polymers. Its unique structural and chemical properties can contribute to the creation of innovative materials with enhanced properties for various applications.

InChI:InChI=1/C6H13NO/c7-6-3-1-2-5(6)4-8/h5-6,8H,1-4,7H2/t5-,6+/m1/s1

Upstream product

• 764-59-0 hex-5-en-1-al 
• 152495-65-3 C₁₃H₁₇NO 
• 821-41-0 5-Hexen-1-ol 
• 113428-55-0 hexahydro-cyclopenta[c]furan-1-one 
• 3205-94-5 1-cyclopentene-1,2-dicarboxylic anhydride 
• 228422-24-0 2-hydroxymethylcyclopentane carboxamide 
• 245115-25-7 (1R,2R)-2-((tert-butoxycarbonyl)amino)cyclopentane-1-carboxylic acid 

Downstream Products

• 117720-32-8 cis-cyclopentanol<1,3>-thiazine 
• 117720-36-2 (4aR,7aS)-Hexahydro-cyclopenta[d][1,3]oxazin-(2Z)-ylidene-phenyl-amine 
• 136315-70-3 (±)-cis-2-((tert-butoxycarbonyl)amino)cyclopentanecarboxylic acid 
• 57043-00-2 (1RS,2SR)-cispentacin 
• 112673-04-8 Dimethyl-[(2S,4aR,7aS)-4-(octahydro-cyclopenta[d][1,3]oxazin-2-yl)-phenyl]-amine 
• 117720-22-6 1-((1S,2R)-2-Hydroxymethyl-cyclopentyl)-3-phenyl-thiourea 
• 112673-03-7 (2S,4aR,7aS)-2-(4-Methoxy-phenyl)-octahydro-cyclopenta[d][1,3]oxazine 
• 112673-00-4 (2S,4aR,7aS)-2-(4-Chloro-phenyl)-octahydro-cyclopenta[d][1,3]oxazine 
• 112673-02-6 (2S,4aR,7aS)-2-p-Tolyl-octahydro-cyclopenta[d][1,3]oxazine 
• 112673-26-4 (r-4,c-2,t-5)-N-methyl-2-p-nitrophenyl-4,5-trimethylenetetrahydro-1,3-oxazine 
• 117720-32-8 trans-cyclopentanol<1,3>-thiazine 
• 117720-36-2 (4aS,7aS)-Hexahydro-cyclopenta[d][1,3]oxazin-(2Z)-ylidene-phenyl-amine 
• 117720-22-6 1-((1S,2S)-2-Hydroxymethyl-cyclopentyl)-3-phenyl-thiourea 

Relevant academic research and scientific papers

TRICYCLIC INHIBITORS OF HEPATITIS B VIRUS

The present invention relates to compounds that are inhibitors of hepatitis B virus (HBV). Compounds of this invention are useful alone or in combination with other agents for treating, ameliorating, preventing or curing HBV infection and related conditions. The present invention also relates to pharmaceutical compositions containing said compounds.

Synthesis and biological activity of some 2-aminopurine carbonucleosides

A series of new one two substituted carbonucleoside analogues (OTC) of purine was synthesized and evaluated against cytomegalovirus and varicella- zoster virus in human embryonic lung (HEL) cells.

Synthesis of racemic and optically active cispentacin (FR109615) using intramolecular nitrone-olefin cycloaddition

Synthesis of racemic and optically active cispentacin ((-)-1) is described. Intramolecular nitrone-olefin cycloaddition of the alkenyl nitrone 7 gave cis-isoxazolidine (±)-8, which was transformed into (±)-1 by sequential reactions involving catalytic hyd